5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine
- Product Name
- 5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine
- CAS No.
- 865362-74-9
- Chemical Name
- 5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine
- Synonyms
- CS-1137;FR 180204;FR-0180204;LM-3319 FR 180204;FR180204, 98%min;FR 180204 (FR180204;FR 180204, 10 mM in DMSO;FR180204/865362-74-9/98%;ERK Inhibitor II, FR180204;FR 180204;FR-180204;FR180204
- CBNumber
- CB72518957
- Molecular Formula
- C18H13N7
- Formula Weight
- 327.34
- MOL File
- 865362-74-9.mol
5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine Property
- Melting point:
- 267 °C
- Density
- 1.55±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMSO: ≥10mg/mL
- pka
- 7.19±0.50(Predicted)
- form
- Yellow solid
- color
- faint yellow to dark yellow
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
- Precautionary statements
-
P264Wash hands thoroughly after handling.
P264Wash skin thouroughly after handling.
P270Do not eat, drink or smoke when using this product.
P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P330Rinse mouth.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- SML0320
- Product name
- FR 180204
- Purity
- ≥98% (HPLC)
- Packaging
- 5mg
- Price
- $161.5
- Updated
- 2025/07/31
- Product number
- 328007
- Product name
- ERK Inhibitor II, FR180204
- Packaging
- 1mg
- Price
- $195.17
- Updated
- 2021/12/16
- Product number
- F1381
- Product name
- FR 180204 [Optimized for Cell Culture]
- Packaging
- 1MG
- Price
- $114
- Updated
- 2025/07/31
- Product number
- F1214
- Product name
- FR 180204
- Packaging
- 5MG
- Price
- $106
- Updated
- 2025/07/31
- Product number
- F1214
- Product name
- FR 180204
- Packaging
- 25MG
- Price
- $378
- Updated
- 2025/07/31
5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine Chemical Properties,Usage,Production
Uses
FR180204 has been used as ERK inhibitor:
- to block extracellular-signal-regulated kinase (ERK) in order to validate whether homeobox B7 (HOXB7) regulates the migration and proliferation process via AKT/mitogen-activated protein kinases (MAPK) signaling
- of extracellular-signal-regulated kinase (ERK) to study the effects of signaling pathway inhibitors on differentiation and cell traction stress
- to determine if phosphorylation of this signaling protein is essential for mesenchymal stromal cell (MSC) derived therapeutic efficacy
Definition
ChEBI: 5-(2-phenyl-3-pyrazolo[1,5-a]pyridinyl)-2H-pyrazolo[3,4-c]pyridazin-3-amine is a member of pyrazoles and a ring assembly.
Biochem/physiol Actions
FR180204 is a potent, cell-permeable, ATP-competitive inhibitor of ERK1 and ERK2 (mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2).
in vivo
FR180204 (100 mg/kg, i.p., b.i.d.) significantly decreases the severity of symptoms and body weight loss in collagen-induced arthritis mice[2].?In a mouse model of dengue virus (DENV) infection, FR180204 limits hepatocyte apoptosis, reduces DENV-induced liver injury, and improves clinical parameters[4].
IC 50
ERK2: 0.14 μM (Ki); ERK1: 0.31 μM (Ki); ERK2: 0.33 μM (IC50); ERK1: 0.51 μM (IC50)
storage
Store at +4°C
5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine Preparation Products And Raw materials
Raw materials
Preparation Products
5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine Suppliers
- Tel
- 800-4238616
- Fax
- +1-888-520-1075 / +1-503-283-1987
- sales@tciamerica.com
- Country
- Americas
- ProdList
- 23653
- Advantage
- 75
View Lastest Price from 5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine manufacturers
- Product
- 5-(2-Phenyl-pyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-ylamine 865362-74-9
- Price
- US $1.00/KG
- Min. Order
- 1KG
- Purity
- 99%
- Supply Ability
- 100KG
- Release date
- 2019-12-20